Skip to main content
. 2020 Mar 26;10(3):e027665. doi: 10.1136/bmjopen-2018-027665

Figure 2.

Figure 2

Kaplan–Meier plot of progression-free survival by KRAS mutation status (A) and baseline ECOG PS (B) (full analysis set). ECOG PS, Eastern Cooperative Oncology Group performance status; PFS, progression-free survival; wt, wild type.